| Trial registration number
|
NCT04860219 |
Full text link
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04860219
|
First author
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
mohamed ghoniem, MD
|
Contact
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
teto2006.km@gmail.com
|
Registration date
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2021-04-26
|
Recruitment status
Last imported at : April 6, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
Unknown
|
Study design
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
participants over 20 years of age
positive for nasopharyngeal swab reverse transcriptase polymerase chain reaction (rt-pcr) for covid-19
blood oxygen saturation (spo2) > 93%.
|
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
pregnant and breastfeeding women
individuals confirmed to be allergic to milk protein
those with a medical history of bronchial hyperactivity or pre-existing respiratory diseases
icu inpatients with covid-19.
|
Number of arms
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
3
|
Funding
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Zagazig University
|
Inclusion age min
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
20
|
Inclusion age max
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Egypt
|
Type of patients
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Mild/moderate disease at enrollment
|
Severity scale
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2: Mild/moderate disease at enrollment
|
Total sample size
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
54
|
primary outcome
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
time to be symptoms free and normal laboratory results
|
Notes
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "200 mg;once daily", "treatment_id": 711, "treatment_name": "Lactoferrin", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "200 mg;twice daily", "treatment_id": 711, "treatment_name": "Lactoferrin", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|